HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Rassner Selected Research

B7-H1 Antigen

1/2021Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Rassner Research Topics

Disease

6Neoplasms (Cancer)
03/2023 - 10/2019
4Multiple Myeloma
01/2021 - 11/2020
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
03/2023 - 10/2019
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 01/2020
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2024
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Residual Neoplasm
01/2022
1Inflammation (Inflammations)
10/2021
1Hemolysis
01/2021
1Human Influenza (Influenza)
01/2021
1Smoldering Multiple Myeloma
01/2021
1Paraproteinemias (Monoclonal Gammopathy)
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Thyroid Neoplasms (Thyroid Cancer)
01/2021
1Anaplastic Thyroid Carcinoma
01/2021
1Thrombotic Microangiopathies
01/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2021
1Hemolytic Anemia
11/2020

Drug/Important Bio-Agent (IBA)

2DNA (Deoxyribonucleic Acid)IBA
03/2023 - 10/2019
2Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2020
2Circulating Tumor DNAIBA
01/2022 - 08/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2024
1Imatinib Mesylate (Gleevec)FDA Link
03/2023
1Interleukin-6 (Interleukin 6)IBA
10/2021
1CytokinesIBA
10/2021
1Oncostatin MIBA
10/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1DecitabineFDA Link
01/2021
1B7-H1 AntigenIBA
01/2021
1pembrolizumabIBA
01/2021
1venetoclaxIBA
01/2021
1daratumumabIBA
01/2021
1lenvatinibIBA
01/2021
1prolinedithiocarbamate (PDTC)IBA
01/2021
1Proteasome InhibitorsIBA
01/2021
1carfilzomibIBA
01/2021
1eculizumabFDA Link
01/2021
1DapsoneFDA Link
11/2020
1Tyrosine Kinase InhibitorsIBA
01/2020

Therapy/Procedure

2Therapeutics
01/2021 - 01/2021
1Blood Component Removal (Apheresis)
01/2021
1Transplantation
01/2021
1Stem Cell Transplantation
01/2021